"Hit-and-run" effects of paramyxoviruses as a basis for chronic respiratory disease

Pediatric Infectious Disease Journal

Volumn 23, Issue 11 SUPPL., 2004, Pages

  Holtzman, Michael J ^a   Shornick, Laurie P ^a   Grayson, Mitchell H ^a   Kim, Edy Y ^a   Tyner, Jeffrey W ^a   Patel, Anand C ^a   Agapov, Eugene ^a   Zhang, Yong ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Airway hyperreactivity; Asthma; Bronchiolitis; Goblet cell metaplasia

Indexed keywords

ASTHMA; CHRONIC INFLAMMATION; CHRONIC RESPIRATORY TRACT DISEASE; CONFERENCE PAPER; CONTROLLED STUDY; EPITHELIUM CELL; HUMAN; HUMAN CELL; INNATE IMMUNITY; MUCOSAL IMMUNITY; PARAMYXOVIRUS; PRIORITY JOURNAL; RNA VIRUS INFECTION; SIGNAL TRANSDUCTION; ANIMAL; CELLULAR IMMUNITY; CHRONIC DISEASE; DISEASE MODEL; GENETICS; IMMUNOLOGY; INFLAMMATION; MOUSE; PATHOPHYSIOLOGY; REVIEW; T LYMPHOCYTE; VIROLOGY; VIRUS INFECTION;

ANIMALS; ASTHMA; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; HUMANS; IMMUNITY, CELLULAR; INFLAMMATION; MICE; PARAMYXOVIRIDAE INFECTIONS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 16244370203     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000144674.24802.c1     Document Type: Conference Paper

References (62)

1. Holtzman MJ, Fabbri LM, O'Byrne PM, et al. Importance of airway inflammation for hyperresponsiveness induced by ozone in dogs. Am Rev Respir Dis. 1983;127:686-690.
2. Murphy KM, Ouyang W, Farrar JD, et al. Signaling and transcription in T helper development. Annu Rev Immunol. 2000;18:451-494.
3. Holtzman MJ, Morton JD, Shornick LP, et al. Immunity, inflammation, and remodeling in the airway epithelial barrier: epithelial-viral-allergic paradigm. Physiol Rev. 2002;82:19-46.
4. Randolph DA, Stephens R, Carruthers CJL, Chaplin DD. Cooperation between Th1 and Th2 cells in a murine model of eosinophilic airway inflammation. J Clin Invest. 1999;104:1021-1029.
5. Hansen G, Berry G, DeKruyff R, Umetsu D. Allergen-specific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation. J Clin Invest. 1999;103:175-183.
6. Holtzman MJ, Look DC, Iademarco MF, et al. Asthma. In: Jameson JL, ed. Principles of Molecular Medicine. Totowa, NJ: Humana Press; 1998:319-227.
7. Gavett SH, O'Hearn DJ, Li X, et al. Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice. J Exp Med. 1995;182:1527-1536.
8. Lack G, Bradley KL, Hamelmann E, et al. Nebulized IFN-γ inhibits the development of secondary allergic responses in mice. J Immunol. 1996; 157:1432-1439.
9. Sur S, Wild JS, Choudhury BK, et al. Long term prevention of allergic lung inflammation in a mouse model of asthma by CpG oligodeoxynucleotides. J Immunol. 1999;162:6284-6293.
10. Finotto S, Neurath NF, Glickman JN, et al. Development of spontaneous airway changes consistent with human asthma in mice lacking T-bet. Science. 2002;295:336-338.
11. Kay AB. Allergy and allergic diseases. N Engl J Med. 2001;344:30-37.
12. Ober C, Moffatt MF. Contributing factors to the pathobiology: the genetics of asthma. Clin Chest Med. 2000;21:245-261.
13. Williams CMM, Galli SJ. Mast cells can amplify airway reactivity and features of chronic inflammation in an asthma model in mice. J Exp Med. 2000;192:455-462.
14. Bandeira-Melo C, Herbst A, Weller PF. Eotaxins: contributing to the diversity of eosinophil recruitment and activation. Am J Respir Cell Mol Biol. 2001;24:653-657.
15. Grayson MH, Holtzman MJ. Lessons from allergic rhinitis versus asthma pathogenesis and treatment. Immunol Allergy Clin North Am. 2002;22:845-869.
16. Melhop PD, van de Rijn M, Goldberg AB, et al. Allergen-induced bronchial hyperreactivity and eosinophilic inflammation occur in the absence of IgE in a mouse model of asthma. Proc Natl Acad Sci USA. 1997;94:1344-1349.
17. Hogan SP, Mould A, Kikutani H, Ramsay AJ, Foster PS. Aeroallergen-induced eosinophilic inflammation, lung damage, and airways hyperreactivity in mice can occur independently of IL-4 and allergen-specific immunoglobulins. J Clin Invest. 1997;99:1329-1339.
18. Wills-Karp M, Luyimbazi J, Xu X, et al. Interleukin-13: central mediator of allergic asthma. Science. 1998;282:2258-2261.
19. Foster PS, Hogan SP, Ramsay AJ, Matthaei KI, Young IG. IL-5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J Exp Med. 1995;183:195-201.
20. Corry DB, Folkesson HG, Warnock ML, et al. Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity. J Exp Med. 1996;183:109-117.
21. Holtzman MJ, Sampath D, Castro M, Look DC, Jayaraman S. The one-two of T helper cells: does interferon-γ knockout the Th2 hypothesis for asthma? Am J Respir Cell Mol Biol. 1996;14:316-318.
22. Hakonarson H, Bjornsdottir US, Ostermann E, et al. Allelic frequencies and patterns of single-nucleotide polymorphisms in candidate genes for asthma and atopy in Iceland. Am J Respir Crit Care Med. 2001;164: 2036-2044.
23. Drazen JM, Arm JP, Austen KF. Sorting out the cytokines of asthma. J Exp Med. 1996;183:1-5.
24. Nakajima S, Look DC, Roswit WT, Bragdon MJ, Holtzman MJ. Selective differences in vascular endothelial- vs. airway epithelial-T cell adhesion mechanisms. Am J Physiol. 1994;267:L422-L432.
25. + gd T cell adherence and tissue retention. J Immunol. 1995;155:1117-1131.
26. Taguchi M, Sampath D, Koga T, et al. Patterns for RANTES secretion and intercellular adhesion molecule-1 expression mediate transepithelial T cell traffic based on analyses in vitro and in vivo. J Exp Med. 1998;187:1927-1940.
27. Holtzman MJ, Castro M, Look DC, O'Sullivan M, Walter MJ. Regulation of epithelial-leukocyte interaction and epithelial immuneresponse genes. In: Busse WW, Holgate ST, eds. Asthma and Rhinitis. Cambridge, MA: Blackwell Scientific; 2000:784-800.
28. Look DC, Keller BT, Rapp SR, Holtzman MJ. Selective induction of intercellular adhesion molecule-1 by interferon-γ in human airway epithelial cells. Am J Physiol. 1992;263:L79-L87.
29. Look DC, Pelletier MR, Holtzman MJ. Selective interaction of a subset of interferon-γ response element binding proteins with the intercellular adhesion molecule-1 (ICAM-1) gene promoter controls the pattern of expression on epithelial cells. J Biol Chem. 1994;269:8952-8958.
30. Look DC, Pelletier MR, Tidwell RM, Roswit WT, Holtzman MJ. Stat1 depends on transcriptional synergy with Sp1. J Biol Chem. 1995;270: 30264-30267.
31. Walter MJ, Look DC, Tidwell RM, Roswit WT, Holtzman MJ. Targeted inhibition of interferon-γ-dependent ICAM-1 expression using dominant-negative Stat1. J Biol Chem. 1997;272:28582-28589.
32. Look DC, Roswit WT, Frick AG, et al. Direct suppression of Stat1 function during adenoviral infection. Immunity. 1998;9:871-880.
33. Koga T, Sardina E, Tidwell RM, et al. Virus-inducible expression of a host chemokine gene relies on replication-linked mRNA stabilization. Proc Natl Acad Sci USA. 1999;96:5680-5685.
34. Castro M, Block SR, Jenkersen MV, et al. Asthma exacerbation after glucocorticoid withdrawal reflects T cell recruitment to the airway. Am J Respir Crit Care Med. 2004;169:842-849.
35. Graham BS, Perkins MD, Wright PF, Karzon DT. Primary respiratory syncytial virus infection in mice. J Med Virol. 1988;26:153-162.
36. Walter MJ, Kajiwara N, Karanja P, Castro M, Holtzman MJ. IL-12 p40 production by barrier epithelial cells during airway inflammation. J Exp Med. 2001;193:339-352.
37. Walter MJ, Holtzman MJ. Epithelial production of IL-12 p80 during viral infection and asthma supports an altered paradigm for airway inflammation. In: Eissa NT, Huston DP, eds. Lung Biology in Health and Disease: Therapeutic Targets in Airway Inflammation. New York: Marcel Dekker; 2003:535-561.
38. Tyner JW, Uchida Y, Kajiwara N, et al. Chemokine CCL5 signals required for survival during viral infection. J Allergy Clin Immunol. 2004;113:S49.
39. Shornick L, Briner D, Lo M, Holtzman MJ. Role of Stat1 in defense against respiratory viruses. In: Proceedings of the Keystone Symposium: Molecular Aspects of Viral Immunity. vol. 1. 2001:56.
40. Dupuis S, Jouanguy E, Al-Hajjar S, et al. Impaired response to interferon-αβ and lethal viral disease in human STAT1 deficiency. Nat Genet. 2003;33:388-391.
41. Sampath D, Castro M, Look DC, Holtzman MJ. Constitutive activation of an epithelial signal transducer and activator of transcription (Stat1) pathway in asthma. J Clin Invest. 1999;103:1353-1361.
42. Domachowske JB, Rosenberg HF. Respiratory syncytial virus infection: immune response, immunopathogenesis, and treatment. Clin Microbiol Rev. 1999;12:298-309.
43. Sigurs N. Epidemiologic and clinical evidence of a respiratory syncytial virus-reactive airway disease link. Am J Respir Crit Care Med. 2001; 163:S2-S6.
44. Walter MJ, Morton JD, Kajiwara N, Agapov E, Holtzman MJ. Viral induction of a chronic asthma phenotype and genetic segregation from the acute response. J Clin Invest. 2002;110:165-175.
45. Shen Y, Zhu H, Shenk T. Human cytomegalovirus IE1 and IE2 proteins are mutagenic and mediate "hit and run" oncogenic transformation in cooperation with the adenovirus E1A proteins. Proc Natl Acad Sci USA. 1997;94:3341-3345.
46. Nevels M, Tauber B, Spruss T, Wolf H, Dobner T. "Hit and run" transformation by adenovirus oncogenes. J Virol. 2001;75:3089-3094.
47. + T cells persist in the lungs following recovery from respiratory virus infections. J Immunol. 2001;166:1813-1822.
48. + T cells that persist in the lungs. J Exp Med. 2001;193:981-986.
49. + cells can switch to interleukin 5 production and induce airway eosinophilia. J Exp Med. 1995;181:1229-1233.
50. + T lymphocytes downregulate T helper cell type 2 cytokine secretion and pulmonary eosinophilia during experimental murine respiratory syncytial virus infection. J Exp Med. 1997;186:421-432.
51. Schwarze J, Cieslewicz G, Joetham A, et al. CD8 T cells are essential in the development of respiratory syncytial virus-induced lung eosinophilia and airway hyperresponsiveness. J Immunol. 1999;162:4207-4211.
52. Ashwell JD, Lu FWM, Vacchio MS. Glucocorticoids in T cell development and function. Annu Rev Immunol. 2000;18:309-345.
53. Vanacker JJ, Palmans E, Kips JC, Pauwels RA. Fluticasone inhibits but does not reverse allergen-induced structural airway changes. Am J Respir Crit Care Med. 2001;163:674-679.
54. Kim EY, Kim JI, Morton JD, et al. Glucocorticoids suppress goblet cell metaplasia in natural and experimental asthma. J Allergy Clin Immunol. 2004;113:S116.
55. Morton JD, Alevy Y, Peltz G, Holtzman MJ. Functional genomics of asthma: role of CLCA3 in goblet cell metaplasia but not airway hyperreactivity. J Allergy Clin Immunol. 2004;113:S205.
56. Noonan TC, Gundel RH, Desai SN, et al. The effects of an anti-CD18 antibody (R15.7) in antigen-induced airway hyperresponsiveness (AH) and cell influx in guinea pigs. Agents Actions. 1991;34:211-213.
57. Gundel RH, Wegner CD, Torcellini CA, et al. Endothelial leukocyte adhesion molecule-1 mediates antigen-induced acute airway inflammation and late-phase airway obstruction in monkeys. J Clin Invest. 1991;88:1407-1411.
58. Fecondo JV, Kent SBH, Boyd AW. Inhibition of intercellular adhesion molecule 1-dependent biological activities by a synthetic peptide analog. Proc Natl Acad Sci USA. 1991;88:2879-2882.
59. Marlin SD, Staunton DE, Springer TA, et al. A soluble form of intercellular adhesion molecule-1 inhibits rhinovirus infection. Nature. 1990;344:70-72.
60. Lineberger DW, Graham DJ, Tomassini JE, Colonno RJ. Antibodies that block rhinovirus attachment map to domain 1 of the major group receptor. J Virol. 1990;64:2582-2587.
61. Horwitz MS, La Cava A, Fine C, et al. Pancreatic expression of interferon-γ protects mice from lethal coxsackievirus B3 infection and subsequent myocarditis. Nat Med. 2000;6:693-697.
62. Yasukawa H, Yajima T, Duplain H, et al. The suppressor of cytokine signaling-1 (SOCS1) is a novel therapeutic target for enterovirus-induced cardiac injury. J Clin Invest. 2003;111:469-478.